Volume | 619,917 |
|
|||||
News | - | ||||||
Day High | 0.01095 | Low High |
|||||
Day Low | 0.00885 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Institute of Biomedical Research Corporation New (PK) | MRES | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0091 | 0.00885 | 0.01095 | 0.00924 | 0.0102 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
16 | 619,917 | $ 0.009112 | $ 5,649 | - | 0.0069 - 0.028 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:00:28 | 1,000 | $ 0.00924 | USD |
Institute of Biomedical Research Corporation New (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 15.20M | 1.64B | 345.00M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Institute of Biomedical ... (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRES Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00775 | 0.01095 | 0.0075 | 0.0092695 | 424,771 | 0.00149 | 19.23% |
1 Month | 0.0123 | 0.0123 | 0.0075 | 0.0094799 | 497,797 | -0.00306 | -24.88% |
3 Months | 0.0205 | 0.026 | 0.007 | 0.0136109 | 1,214,851 | -0.01126 | -54.93% |
6 Months | 0.0085 | 0.028 | 0.0069 | 0.0173529 | 1,977,996 | 0.00074 | 8.71% |
1 Year | 0.0121 | 0.028 | 0.0069 | 0.0167469 | 1,224,819 | -0.00286 | -23.64% |
3 Years | 0.0004 | 0.045 | 0.0002 | 0.0155187 | 1,171,217 | 0.00884 | 2,210.0% |
5 Years | 0.0011 | 0.045 | 0.0002 | 0.0147791 | 1,008,903 | 0.00814 | 740.0% |
Institute of Biomedical ... (PK) Description
The Institute of Biomedical Research is a Nevada Corporation trading as M2Bio Science. We are a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research. M2Bio's mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies. As one of a handful of companies in the world, M2Bio is actively researching the magic mushroom compound psilocybin by funding research at a South African University . The exploratory research is aiming to discover novel indications for medical conditions such as depression, inflammation, and substance addiction. The company also owns and operates three consumer goods brands Medspresso, Dr. AnnaRx, and Liviana. The brands span across a wide range of premium CBD- and mushroom-infused consumer goods including bioceuticals, health and wellness, and precision foods and beverages. With operations currently based in Cape Town, South Africa the company and its brands are positioned in the high-value market segment. |